1. Home
  2. CTXR vs GDHG Comparison

CTXR vs GDHG Comparison

Compare CTXR & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • GDHG
  • Stock Information
  • Founded
  • CTXR 2007
  • GDHG 2008
  • Country
  • CTXR United States
  • GDHG China
  • Employees
  • CTXR N/A
  • GDHG N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • CTXR Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • CTXR 22.6M
  • GDHG 19.4M
  • IPO Year
  • CTXR N/A
  • GDHG 2023
  • Fundamental
  • Price
  • CTXR $1.29
  • GDHG N/A
  • Analyst Decision
  • CTXR Strong Buy
  • GDHG
  • Analyst Count
  • CTXR 3
  • GDHG 0
  • Target Price
  • CTXR $53.00
  • GDHG N/A
  • AVG Volume (30 Days)
  • CTXR 414.8K
  • GDHG 15.4K
  • Earning Date
  • CTXR 08-12-2025
  • GDHG 07-11-2025
  • Dividend Yield
  • CTXR N/A
  • GDHG N/A
  • EPS Growth
  • CTXR N/A
  • GDHG N/A
  • EPS
  • CTXR N/A
  • GDHG N/A
  • Revenue
  • CTXR N/A
  • GDHG $16,666,899.00
  • Revenue This Year
  • CTXR N/A
  • GDHG N/A
  • Revenue Next Year
  • CTXR $851.67
  • GDHG N/A
  • P/E Ratio
  • CTXR N/A
  • GDHG N/A
  • Revenue Growth
  • CTXR N/A
  • GDHG N/A
  • 52 Week Low
  • CTXR $0.65
  • GDHG $2.40
  • 52 Week High
  • CTXR $12.84
  • GDHG $1,968.41
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 50.95
  • GDHG N/A
  • Support Level
  • CTXR $1.11
  • GDHG N/A
  • Resistance Level
  • CTXR $1.52
  • GDHG N/A
  • Average True Range (ATR)
  • CTXR 0.08
  • GDHG 0.00
  • MACD
  • CTXR 0.02
  • GDHG 0.00
  • Stochastic Oscillator
  • CTXR 39.03
  • GDHG 0.00

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: